Combating Counterfeits

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar d.

Combating Counterfeits in Pharmaceuticals

Key Facts – Pharmaceutical Counterfeiting

  • Counterfeit medicines represent an estimated $200–$432 billion annual market (OECD, WHO) .
  • World Health Organization (WHO) reports 1 in 10 medical products in low- and middle-income countries is substandard or falsified.
  • Fake medicines can contain incorrect or harmful ingredients, leading to adverse reactions, treatment failure, and death.
  • Over 50% of medicines purchased online from illicit websites are counterfeit or substandard (WHO).
  • Interpol’s Operation Pangea XV (2022) seized 3 million counterfeit medicines worth over $11 million in one week.
  • Regulatory Response:
      -EU Falsified Medicines Directive (FMD) mandates serialization and tamper-evident packaging.
    • -US Drug Supply Chain Security Act (DSCSA) requires full track-and-trace by 2024.
  • Rapid growth in pharma demand in emerging markets + weak enforcement makes those regions more vulnerable.


Why Counterfeit Medicines Matter

  • Counterfeit medicines cause patient harm, adverse reactions, and even fatalities
  • WHO estimates ~10% of medicines in low- and middleincome countries are substandard or falsified
  • Significant economic losses to the pharmaceutical industry (tens of billions USD annually)
  • Erosion of public trust in healthcare systems

Key Features

Medicine Packaging Authentication

Covert/forensic codes + QR for patient and pharmacist verification, offline capable

Bottle/Blister Pack Security

Tamper-evident seals, unique serials to deter refilling or substitution

Regulatory Certifications

Secure digital licenses for distributors and pharmacies

Analytics

Real-time mapping of counterfeit hotspots and illegal supply chains

KPIs & Expected Impact

  • % of pharma units labeled & verified
  • Reduction in counterfeit incidents and product returns
  • Median time-to-verify <1s in offline conditions


LIT Proposed Architecture (High Level)

  • Secure serial generation + cryptographic signing
  • Multi-layer labels (overt, covert, digital QR/NFC)
  • Verification apps (iOS/Android)
  • Back office for issuance control, case management, dashboards, and regulator API integration

LIT Combating Counterfeits in Pharmaceuticals